However, the difference did not reach statistical significance and is small compared to what may be considered clinically meaningful.
← all excerpts
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study.
1
—
—